Firstsense Medical

FirstSense Medical is developing a revolutionary breast cancer tester with 95% sensitivity (detection rate), that is painless, radiation free, takes 10 minutes and performed in the doctor’s office. One in eight women is diagnosed with breast cancer. In 2011, there were 230,000 cases of invasive and 50,000 cases of non-invasive breast cancer in the U.S and 40,000 deaths. When caught early, 5-year survival rate is 98 - 100%. FirstSense Medical has exclusive world rights to technology that has manually analyzed over 1,000,000 women. FirstSense emulates this technology with a robot and sophisticated software.